Revenue Growth QoQ: Evolus (EOLS)

Corporate company logo of Evolus Inc (EOLS)

Effective management at Evolus, Inc. (EOLS) ensures market share expansion and high margins. The quarterly revenue growth history visualizes this progress, where the value 13.30 describes the current level. Rapid business scaling is supported by a concentration on a single high-demand drug without excessive research expenditures. An affordable pricing policy and active promotional campaigns allow the company to attract a younger audience.

Evolus Inc (EOLS) - Quarterly Revenue Increase from 07/04/2022 to 11/20/2026

Financial and market metric breakdowns for Evolus (EOLS)

- share price and expert price forecast:
- company stock exchange capitalization indicators:
- cash and cash flow metrics:
Initial company analysis:evolus.com - EOLS
Mass-produced product of evolus.com

For Evolus, Inc. (EOLS), quarterly revenue growth serves as an indicator of expansion within the aesthetic medicine sector, measuring the relative change in sales volume between reporting periods. Analyzing the current quarterly revenue growth rate allows for an assessment of the effectiveness of the aggressive sales strategy and the company's ability to scale cash flows. Positive dynamics confirm the demand for products at the intersection of the pharmaceutical and beauty industries. A stable trend in this metric demonstrates the high market resilience of the business.

Competitors of Evolus, Inc.

HCA Holdings - Quarterly Revenue Growth|Quarterly Revenue Increase THC (Tenet Healthcare)|FMS: Quarterly Revenue Growth|Sales Growth QoQ SOLV|Revenue Growth QoQ Encompass|Quarterly Revenue Growth uhsinc.com|Revenue Growth QoQ DaVita (DVA)|Quarterly Sales Growth Rate radnet.com|Quarterly Revenue Growth OPCH (optioncarehealth.com)|SGRY (Surgery Partners) - Revenue Dynamics QoQ|PINC - Revenue Growth QoQ|Quarterly Sales Growth Rate America's Best Contacts & Eyeglasses EYE|PGNY: Quarterly Revenue Growth|ARDT (Ardent Health Partners) - Revenue Growth QoQ|SEM (selectmedical.com) - Quarterly Revenue Growth|Revenue Growth QoQ ASTH|Quarterly Revenue Growth MD|Revenue Growth QoQ USPH (US Physical Therapy Inc)|Revenue Growth QoQ The Pennant Group, Inc. PNTG|Quarterly Revenue Increase ORGO|NUTX - Revenue Growth QoQ|AUNA - Quarterly Revenue Growth|SBC Medical Group Inc (SBC) - Revenue Growth QoQ|Community Health Corp - Quarterly Revenue Increase|SKIN (beautyhealth.com) - Quarterly Revenue Growth|Quarterly Sales Growth MediWound Ltd. (MDWD)|Quarterly Revenue Growth BTMD|The Joint Corporation - Sales Growth QoQ|DocGo - Quarterly Sales Growth|Quarterly Revenue Growth P3 Health Partners PIII|GANX - Revenue Growth QoQ|EUDA Health Holdings - Sales Change QoQ|Basel Medical Group Limited (BMGL) - Revenue Growth QoQ|Quarterly Revenue Growth Rate CollPlant (CLGN)|CUPR (Cuprina Holdings (Cayman) Ltd.) - Quarterly Revenue Growth|Quarterly Revenue Growth Rate Concord Medical Corp CCM|Revenue Growth QoQ American Shared Hospital (AMS)|MRM (medirom.co.jp) - Quarterly Revenue Increase|Quarterly Revenue Growth ALBT (Avalon GloboCare Corp)|Sales Change QoQ DHAI (DIH Holding US)|XAGE - Revenue Growth QoQ|Quarterly Sales Growth Rate NewGenIvf Group Limited NIVF|ATI Physical Therapy Corp (ATIP) - Revenue Growth QoQ|Quarterly Sales Growth CareMax, Inc.|Quarterly Sales Growth KDLY|MODV (ModivCare Inc) - Sales Change QoQ|Revenue Growth QoQ Novo Integrated Sciences Corp (NVOS)|Quarterly Revenue Growth SunLink Health Systems, Inc (SSY)|Quarterly Revenue Growth BACK (IMAC Holdings Inc)